Primary |
Vitamin Supplementation |
39.5% |
Asthma |
7.0% |
Glaucoma |
7.0% |
Hypertension |
7.0% |
Arthralgia |
4.7% |
Abdominal Discomfort |
2.3% |
Age-related Macular Degeneration |
2.3% |
Anaemia |
2.3% |
Anxiety Disorder |
2.3% |
Arthritis |
2.3% |
Blood Cholesterol Increased |
2.3% |
Cataract |
2.3% |
Cerebrovascular Accident |
2.3% |
Contraception |
2.3% |
Depression |
2.3% |
Dysmenorrhoea |
2.3% |
Epigastric Discomfort |
2.3% |
Epilepsy |
2.3% |
Hyperlipidaemia |
2.3% |
Hypothyroidism |
2.3% |
|
Choking |
32.4% |
Faeces Discoloured |
5.9% |
Nausea |
5.9% |
No Adverse Event |
5.9% |
Vomiting |
5.9% |
Asthenia |
2.9% |
Chest Discomfort |
2.9% |
Coeliac Disease |
2.9% |
Dizziness |
2.9% |
Drug Interaction |
2.9% |
Dyspnoea |
2.9% |
Flatulence |
2.9% |
Hallucination |
2.9% |
Headache |
2.9% |
Hyperhidrosis |
2.9% |
Hypersensitivity |
2.9% |
Hypertriglyceridaemia |
2.9% |
Infusion Related Reaction |
2.9% |
Malaise |
2.9% |
Neuropathy Peripheral |
2.9% |
|
Secondary |
Foetal Exposure During Pregnancy |
22.2% |
Drug Use For Unknown Indication |
13.3% |
Product Used For Unknown Indication |
8.5% |
Diabetes Mellitus |
6.7% |
Depression |
5.5% |
Hyperemesis Gravidarum |
5.3% |
Hypersensitivity |
5.2% |
Drug Exposure During Pregnancy |
4.3% |
Asthma |
4.2% |
Gastrooesophageal Reflux Disease |
3.6% |
Hypertension |
2.7% |
Anxiety |
2.3% |
Migraine |
2.3% |
Vitamin Supplementation |
2.3% |
Arthralgia |
2.0% |
Maternal Exposure During Pregnancy |
2.0% |
Cd4 Lymphocytes Decreased |
1.9% |
Chest Pain |
1.9% |
Muscle Spasms |
1.9% |
Fluid Retention |
1.8% |
|
Memory Impairment |
13.9% |
Vomiting |
12.5% |
Cleft Palate |
9.7% |
Myocardial Infarction |
8.3% |
Nausea |
6.9% |
Premature Baby |
5.6% |
Tremor |
5.6% |
Completed Suicide |
4.2% |
Blood Creatinine Decreased |
2.8% |
Cleft Lip |
2.8% |
Death |
2.8% |
Drug Ineffective |
2.8% |
Emotional Disorder |
2.8% |
Headache |
2.8% |
Hydrocele |
2.8% |
Hyperbilirubinaemia |
2.8% |
Hyperhidrosis |
2.8% |
Medication Error |
2.8% |
Muscle Spasms |
2.8% |
Sneezing |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
30.4% |
Drug Use For Unknown Indication |
23.0% |
Hypertension |
5.3% |
Pain |
4.4% |
Depression |
4.0% |
Rheumatoid Arthritis |
3.3% |
Crohn's Disease |
3.2% |
Multiple Myeloma |
3.1% |
Vitamin Supplementation |
2.7% |
Prophylaxis |
2.7% |
Anxiety |
2.2% |
Supplementation Therapy |
2.2% |
Blood Cholesterol Increased |
2.1% |
Smoking Cessation Therapy |
1.9% |
Osteoporosis |
1.9% |
Gastrooesophageal Reflux Disease |
1.7% |
Medical Diet |
1.7% |
Diabetes Mellitus |
1.6% |
Asthma |
1.5% |
Hiv Infection |
1.4% |
|
Vomiting |
11.7% |
Weight Decreased |
11.4% |
Nausea |
7.4% |
Weight Increased |
6.8% |
Death |
5.7% |
Drug Ineffective |
5.6% |
Pain |
5.5% |
Urinary Tract Infection |
4.5% |
Fatigue |
4.4% |
Pneumonia |
4.3% |
Vision Blurred |
4.1% |
Rash |
3.7% |
Headache |
3.3% |
Pyrexia |
3.3% |
Diarrhoea |
3.2% |
Pulmonary Embolism |
3.2% |
Dyspnoea |
3.1% |
Somnolence |
3.0% |
Pain In Extremity |
2.9% |
Paraesthesia |
2.9% |
|
Interacting |
Hypertension |
16.7% |
Depression |
7.6% |
Diabetes Mellitus |
7.6% |
Blood Cholesterol Increased |
6.1% |
Catatonia |
6.1% |
Pain |
6.1% |
Anxiety |
4.5% |
Arthritis |
4.5% |
Drug Use For Unknown Indication |
4.5% |
Macular Degeneration |
4.5% |
Oesophagitis |
4.5% |
Atrial Fibrillation |
3.0% |
Blood Cholesterol |
3.0% |
Constipation |
3.0% |
Dementia |
3.0% |
Hangover |
3.0% |
Hypertonic Bladder |
3.0% |
Malaise |
3.0% |
Open Wound |
3.0% |
Panic Attack |
3.0% |
|
Drug Interaction |
16.7% |
Incorrect Dose Administered |
11.1% |
Oedema Peripheral |
11.1% |
Vomiting |
11.1% |
Weight Decreased |
11.1% |
Dizziness |
5.6% |
Heart Rate Increased |
5.6% |
Myalgia |
5.6% |
Myocardial Infarction |
5.6% |
Pollakiuria |
5.6% |
Vision Blurred |
5.6% |
Wrong Technique In Drug Usage Process |
5.6% |
|